Anthony M. Hunter
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 33
- Acute Myeloid Leukemia Research 23
- Chronic Myeloid Leukemia Treatments 15
- Multiple Myeloma Research and Treatments 5
- Genetics 26
- Myeloproliferative Neoplasms: Diagnosis and Treatment 22
- Chronic Lymphocytic Leukemia Research 6
- Hemoglobinopathies and Related Disorders 5
- Co-authors
- David A. Sallman (11 shared papers)Eric Padron (16 shared papers)Rami S. Komrokji (12 shared papers)Ling Zhang (2 shared papers)Jeffrey E. Lancet (8 shared papers)Najla Al Ali (7 shared papers)Kendra Sweet (5 shared papers)Chetasi Talati (5 shared papers)
- Journals
- Blood (17 papers)Journal of Clinical Oncology (4 papers)HemaSphere (2 papers)Leukemia (2 papers)Best Practice & Research Clinical Haematology (2 papers)
- Partner nations
- United StatesItalySpain
In The Last Decade
Anthony M. Hunter
36 papers receiving 328 citations
Peers
Comparison fields: 5 of 43
- Hematology 249
- Genetics 116
- Cancer Research 25
- Oncology 43
- Pathology and Forensic Medicine 27
Countries citing papers authored by Anthony M. Hunter
This map shows the geographic impact of Anthony M. Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony M. Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony M. Hunter more than expected).
Fields of papers citing papers by Anthony M. Hunter
This network shows the impact of papers produced by Anthony M. Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony M. Hunter. The network helps show where Anthony M. Hunter may publish in the future.
Co-authors
The 25 scholars most cited alongside Anthony M. Hunter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 63 | |
| 2 | 2019 | 56 | |
| 3 | 2021 | 50 | |
| 4 | 2018 | 22 | |
| 5 | 2019 | 14 | |
| 6 | 1976 | 14 | |
| 7 | 2019 | 11 | |
| 8 | 2012 | 11 | |
| 9 | 2022 | 10 | |
| 10 | 2021 | 10 | |
| 11 | 2022 | 9 | |
| 12 | 2022 | 5 | |
| 13 | 2024 | 5 | |
| 14 | 2019 | 5 | |
| 15 | 2020 | 5 | |
| 16 | 2021 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2023 | 3 | |
| 19 | 2023 | 3 | |
| 20 | 2023 | 3 |
About Anthony M. Hunter
Anthony M. Hunter is a scholar working on Hematology, Genetics, Molecular Biology, Rheumatology and Pathology and Forensic Medicine, having authored 43 papers that have together received 331 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (23 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers), Chronic Myeloid Leukemia Treatments (15 papers), Chronic Lymphocytic Leukemia Research (6 papers), Protein Degradation and Inhibitors (5 papers), Hemoglobinopathies and Related Disorders (5 papers), Multiple Myeloma Research and Treatments (5 papers) and Eosinophilic Disorders and Syndromes (4 papers). The work is most often cited by research in Hematology (249 citations), Genetics (116 citations), Cancer Research (25 citations), Oncology (43 citations) and Pathology and Forensic Medicine (27 citations). Anthony M. Hunter has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include David A. Sallman, Eric Padron, Rami S. Komrokji, Ling Zhang, Jeffrey E. Lancet, Najla Al Ali, Kendra Sweet, Chetasi Talati, R.G. Clark and Onyee Chan. Their work appears in journals such as Blood, Journal of Clinical Oncology, HemaSphere, Leukemia and Best Practice & Research Clinical Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.